HaiAI123

Curated Global AI Tools Directory

Industry update
Flat

Boltz raises $110M Series A for AI-driven drug discovery

11/20/2026 — 11/20, 06:17·1 sources (all)·1 reports (all)

Key takeaways

  • Boltz PBC, a healthcare AI startup, has raised $110 million in Series A funding led by Bessemer, with participation from Greycroft, Andreess…

Background & analysis

On November 20, 2026, SiliconANGLE reported that Boltz PBC, a medical AI startup that develops artificial intelligence models for pharmaceutical researchers, has raised $110 million in funding. The round was a Series A investment led by Bessemer. Boltz stated on Wednesday that the funding attracted a large group of both new and returning backers, with the investor consortium including Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital, Hummingbird, and others. According to the company, the capital will be used to accelerate small molecule research. At this point, the publicly available information stops at the completion of the financing round and the company's statement on its intended use of the funds, with no further developments reported yet.

AI-generated from 1 reports · updated 2 days ago

updream
24-hour heatHeat index 25 · peak 42 · 23h ago
24 hours agonow

Reports on this story headlines open the original

Nov 20
  1. SiliconANGLE reported that Boltz PBC, a startup building AI models for pharmaceutical researchers, raised $110 million in a Series A round led by Bessemer. Greycroft, Andreessen Horowitz and other investors participated. The company said the funding will speed up small molecule research.

    SiliconANGLEAI score 52

Other stories people are talking about

How is heat calculated?About the method

Heat counts how many independent sources covered a story in the last 48 hours: one source counts once no matter how many posts it published, decaying with a 24-hour half-life. What ranks first is what many people are talking about.

This page aggregates public feeds. Headlines and summaries are machine-organized and remain the property of the original authors; verify important facts at the source. If you believe a headline or summary infringes your rights, email the contact address in the footer with the page URL and basis of your claim, and we will remove or replace it after review.

Surge
Discussion rising fast
New
First report within 6 hours
Rising
Still gathering discussion

Back to AI industry updates →